Turner Heather D

CIK 00014035716 companiesFOSTER CITY, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001403571

Recent Transactions

50 trades

Award
Terns Pharmaceuticals, Inc.$TERN
Stock Option (Right to Buy)
2026-02-01+1,697→ 1,697 total
Award
LB PHARMACEUTICALS INC$LBRX
Employee Stock Option (Right to Buy)
2025-09-10+175,706→ 175,706 total
Disposition to Issuer
LB PHARMACEUTICALS INC$LBRX
Employee Stock Option (Right to Buy)
2025-09-10−175,706→ 0 total
Award
LB PHARMACEUTICALS INC$LBRX
Employee Stock Option (Right to Buy)
2025-09-10+7,857→ 7,857 total
Disposition to Issuer
LB PHARMACEUTICALS INC$LBRX
Employee Stock Option (Right to Buy)
2025-09-10−7,857→ 0 total
Award
LB PHARMACEUTICALS INC$LBRX
Employee Stock Option (Right to Buy)
2025-09-10+971,828→ 971,828 total
Award
Terns Pharmaceuticals, Inc.$TERN
Stock Option (Right to Buy)
2025-06-11+45,000→ 45,000 total
Award
Terns Pharmaceuticals, Inc.$TERN
Stock Option (Right to Buy)
2024-11-18+64,000→ 64,000 total
Award
Lyell Immunopharma, Inc.$LYEL
Option (right to buy)
2022-03-16+300,000→ 300,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right-to-Buy)
2019-02-25+115,500→ 115,500 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2019-02-25+19,250→ 19,250 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2018-02-28+200,000→ 200,000 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2018-02-09$39.66/sh−733→ 71,656 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2018-02-09$37.38/sh−4,123→ 72,989 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2018-02-09$41.69/sh−1,562→ 69,494 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2018-02-09$40.62/sh−600→ 71,056 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2018-02-09$36.63/sh−4,596→ 77,112 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2018-02-09$38.63/sh−600→ 72,389 total
Tax Payment
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2018-02-06$35.80/sh−4,434→ 81,708 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2017-02-09$15.70/sh−11,582→ 86,775 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2017-02-09$16.16/sh−633→ 86,142 total
Award
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2017-02-06+49,500→ 98,357 total
Award
Atara Biotherapeutics, Inc.$ATRA
Employee Stock Option (Right to Buy)
2016-09-22+40,000→ 40,000 total
Award
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2016-02-09+48,857→ 48,857 total
Award
Atara Biotherapeutics, Inc.$ATRA
Employee Stock Option (Right to Buy)
2015-12-17+65,000→ 65,000 total
Award
Atara Biotherapeutics, Inc.$ATRA
Employee Stock Option (Right to Buy)
2015-08-03+130,000→ 130,000 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2015-02-03+153,050→ 153,050 total
Exercise/Conversion
Orexigen Therapeutics, Inc.
Common Stock
2014-12-02$1.66/sh+22,643→ 22,643 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2014-12-02$6.00/sh−22,643→ 0 total
Exercise/Conversion
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2014-12-02−22,643→ 656,932 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2014-11-25$6.00/sh−7,382→ 0 total
Exercise/Conversion
Orexigen Therapeutics, Inc.
Common Stock
2014-11-25$1.66/sh+7,382→ 7,382 total
Exercise/Conversion
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2014-11-25−7,382→ 679,575 total
Exercise/Conversion
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2014-11-24−24,006→ 686,957 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2014-11-24$5.77/sh−24,006→ 0 total
Exercise/Conversion
Orexigen Therapeutics, Inc.
Common Stock
2014-11-24$1.66/sh+24,006→ 24,006 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2014-09-22$4.46/sh−300,000→ 0 total
Exercise/Conversion
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2014-09-22−300,000→ 710,963 total
Exercise/Conversion
Orexigen Therapeutics, Inc.
Common Stock
2014-09-22$1.66/sh+300,000→ 300,000 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2014-02-07+205,000→ 205,000 total
Award
Orexigen Therapeutics, Inc.
Common Stock
2013-11-29$5.34/sh+3,980→ 3,980 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2013-02-15+240,000→ 240,000 total
Exercise/Conversion
Orexigen Therapeutics, Inc.
Common Stock
2012-07-17$1.66/sh+82,433→ 82,433 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2012-07-17$7.68/sh−82,433→ 0 total
Exercise/Conversion
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2012-07-17−82,433→ 1,010,963 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2012-01-25+350,000→ 350,000 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2011-07-25−1,093,396→ 1,093,396 total
Disposition to Issuer
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2011-07-22−107,000→ 0 total
Disposition to Issuer
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2011-07-22−115,000→ 0 total
Disposition to Issuer
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2011-07-22−100,000→ 0 total

Companies

Recent Filings

Address

C/O TERNS PHARMACEUTICALS, INC. 1065 EAST HILLSDALE BLVD., SUITE 100

FOSTER CITY, CA, 94404

View on SEC.gov